InvestorsHub Logo
Followers 4
Posts 140
Boards Moderated 0
Alias Born 02/29/2012

Re: slazenger7 post# 63714

Wednesday, 10/16/2013 11:36:44 AM

Wednesday, October 16, 2013 11:36:44 AM

Post# of 75926
Because the Mammoview is a very specific medical procedure that has not yet been fully adopted by medical facilities within the US.

The predominant Mammoview customers in the US have been government organizations and a few universities, all in a research realm.
There has been some reporting of hospitals using it but I would suspect that it is related to these institutions.

Many of the articles on studies I have read states that the commonly used mammography screening has provided similar results in identifying breast cancer lesions as the Mammoview. However using the mammography has yielded a 25% misdiagnosis in properly identifying lesions where the Mammoview has not. For what ever reason many US medical facilities, so far, have mitigated this 25% deficiency and have not replaced their dated mammography screening machines with the Mammoview. Yet.

I do not see this as being the case in Canada and in Europe for two reason. 1, According to a Global Cancer report, there are far more new cancer diagnosis and misdiagnosis in Canada and The European Union than there are in the US annualy. 2, Canada and the EU have establish socialized medicine programs that are working hard to eliminate the growing breast cancer epidemic.

I believe that Canada and the EU will adopt the Mammoview as the standard breast cancer early detection system and over time the US will follow suite. Especially as the Mammoview continues to evolve and the mammography becomes more obsolete.

All in my opinion of course.

GLTA